Sunshine Biopharma Inc. (SBFM)
NASDAQ · Healthcare
Sunshine Biopharma Inc. Net Income 2017–2025
Sunshine Biopharma Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Sunshine Biopharma Inc. net income for the quarter ending March 31, 2026 was -1.2 M, a 5.43% increase year-over-year.
- Sunshine Biopharma Inc. net income for the twelve months ending March 31, 2026 was -5.1 M, a 40.00% increase year-over-year.
- Sunshine Biopharma Inc. annual net income for 2025 was -6.0 M, a 16.39% increase from 2024.
- Sunshine Biopharma Inc. annual net income for 2024 was -5.1 M, a 13.94% increase from 2023.
- Sunshine Biopharma Inc. annual net income for 2023 was -4.5 M, a 83.15% decrease from 2022.
- Sunshine Biopharma Inc. annual net income for 2022 was -26.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Sunshine Biopharma Inc. Net Income — FAQ
Sunshine Biopharma Inc. (SBFM) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Sunshine Biopharma Inc.'s net income?
Sunshine Biopharma Inc. (SBFM) reported net income of -$6M for fiscal 2025.
Where can I see SBFM's net income history?
The chart and table above show Sunshine Biopharma Inc.'s net income by year and by quarter, including the growth rate.